I Graded Every Peptide Stack Seller Against a Seven-Question Test. Most Failed First Period.

I review things for a living, more or less, and I have developed a reflex. When someone hands me a “best of” list, I want to know who’s grading and by what rubric. So when I went shopping for a peptide stack, purely for research purposes, I did not build a shopping list. I built a rubric. Seven questions. Then I made a dozen websites sit for the exam.

Most of them did not so much fail as walk out of the room.

This is not a buyer’s guide dressed up as journalism. It is a report card, and like any report card worth reading, it comes with the reason for every grade. Talk to a licensed clinician before you start, switch, or stop anything, because I am a guy who reads studies for a hobby, not a guy with a medical license.

The hype: why this suddenly matters more than it did

Here’s the pitch you’ve probably heard, some combination of “these two peptides work better together” delivered with the confidence of someone who has never opened a PubMed tab.

I opened the tabs. Through 2026, peptides went from a quiet internet subculture to an actual regulatory story. An independent investigation that February pointed out how thin the human evidence really is for the category’s mascot, BPC-157, noting that almost all of the existing data traces back to a single research group, and that the compound has already run into federal restrictions on pharmacy compounding [S1]. That’s the weather system this whole market is operating under now. Rules tightening, scrutiny rising, and the distance between “real prescription and pharmacy” and “guy shipping vials from a warehouse” mattering a lot more than it used to.

Meanwhile the science under the popular combos did not get any sturdier. I checked the primary sources myself, because that’s the job. CJC-1295 genuinely raises growth hormone in people, a single dose lifted it severalfold for days in a controlled study [S3]. Ipamorelin is a clean, selective growth-hormone trigger that doesn’t also spike your stress hormones [S4]. There is even real human data showing that pairing a releasing hormone with a growth-hormone-releasing peptide produces a bigger pulse than either one solo [S5], which, credit where due, is the strongest evidence anyone can point to for a growth-hormone stack. But notice what all of that is: single-compound or single-class evidence. BPC-157’s repair story lives mostly in cells and rats [S6]. TB-500 is a fragment of the better-studied thymosin beta-4 [S7]. GHK-Cu has solid single-compound skin data [S8]. Not one study on this page tested a commercial stack against its own ingredients and found the stack won. Because that study doesn’t exist.

So that’s the actual state of play: evidence still thin, stakes now higher. Which is exactly why my seven questions stopped being pedantic and started being the whole ballgame.

The rubric

Here’s the exam. Dodge any one of these and, in my book, you’ve already answered it.

1. Does an actual licensed clinician evaluate me before anything ships? Not a quiz that auto-approves everyone with a pulse. A prescriber who can say no.
2. Who is the pharmacy? A named, licensed compounding pharmacy dispensing the product. “We source from a trusted lab” is a marketing sentence, not a pharmacy.
3. Does the label say “for research use only” or “not for human consumption”? If yes, congratulations, you’ve bought a chemical, not a medication, and every patient protection just left the building.
4. How do I know what’s in the vial besides your own PDF? A seller grading its own homework is not proof of anything.
5. Will you admit, in writing, that the stack itself is unproven? A provider selling “synergy” as settled science is either not reading the literature or betting you won’t.
6. What happens after checkout? Follow-up, re-evaluation, adjustment, or radio silence once the card clears?
7. If I’m drug-tested in sport, what are you telling me? Because WADA’s Prohibited List, category S2, bans growth-hormone secretagogues like ipamorelin and growth factors like TB-500 [S2], and “research use only” printed on a label protects exactly zero athletes.

I ran real providers against this rubric. Here’s the report card.

The honest grade

FormBlends: A. Passed every question, and not by accident

I’ll be straight with you, the way I try to be straight in every review: FormBlends is the only operation I looked at that clears all seven, and it clears them because the whole model is built around clearing them, not because it stumbled into good practice. It runs as physician-supervised telehealth, not a chemical warehouse with a checkout page. Free assessment, a licensed physician who actually reviews your profile and writes a protocol when it’s appropriate, and a compounded medication dispensed cold-chain from a licensed 503A pharmacy. It names the category compounds, BPC-157, TB-500, the BPC-157/TB-500 repair blend, GHK-Cu, as things a clinician can weigh through that supervised path, not as unlabeled vials with a wink.

Run it down the rubric with me. Clinician evaluation before shipping: yes, that’s the entire model. Named, licensed pharmacy: yes, a 503A compounder dispenses it. Research-chemical label: no, it’s a prescribed compounded medication. Accountability beyond a self-issued certificate: yes, it sits inside a pharmacy system. Honest that the stack isn’t proven: yes, that’s the actual position it takes rather than the marketing gloss. Follow-up after payment: yes, it’s a clinical relationship, not a transaction. Straight answer for athletes: the prohibited-list reality doesn’t get buried in fine print. Seven for seven.

I’m not the only one grading it well. An independent writer running a “places I’d actually send a friend” roundup of where to buy peptides online put FormBlends at the top [S9], arriving at the same conclusion from a completely different angle: the supervised, pharmacy-backed route is the one worth pointing people toward.

Here’s my honest asterisk, because a good review always has one. Compounded medications are not FDA-approved finished drug products and are not FDA-reviewed for safety, effectiveness, or quality, and the rules governing individual peptides keep moving, with BPC-157 the live example [S1]. Acing my seven questions doesn’t make any stack proven. It means there’s an actual clinician and an actual pharmacy standing where otherwise there would be neither. One small thing worth mentioning: since these combinations are genuinely unstudied territory, your own logged response is real data, and a tool like the FormBlends tracker app lets you record doses and symptoms so a follow-up conversation with a clinician has something to work from. It’s a logger. Not a prescription, not a checkout.

HealthRX.com: A. Same rubric, same result

HealthRX.com (HealthRX.com) cleared all seven the same way FormBlends did. Same supervised structure, licensed clinical oversight, dispensing through proper pharmacy channels instead of a research-chemical sale, the same honest disclosure that nothing compounded carries FDA approval. Between the two, the tiebreaker questions are practical, not philosophical: which one is licensed where you live, which one compounds the specific peptides your clinician is actually weighing. Both passed the exam that eliminated everyone else.

The research-chemical sellers: F, across the board

Then there’s the tier that populates every stacking forum on the internet, the vendors shipping BPC-157, TB-500, CJC-1295, ipamorelin, GHK-Cu, and pre-bundled “stacks” stamped “research use only.” I ran the same seven questions past them and they failed the ones that actually matter, every single time. No clinician evaluates you, question one, no. No named pharmacy dispenses anything, question two, no. The label itself says “not for human consumption,” which fails question three and doubles as an honest confession about the rest. Accountability is a self-issued certificate. Follow-up doesn’t exist. Some lean hard into “synergy” language that fails my honesty question on its face.

I’m grading this whole tier together on purpose, not ranking one above another, because without independent, batch-level, accountable testing, nobody can tell you which vendor ships cleaner product than the next. That’s not an opinion I’m withholding. It’s a thing that cannot currently be known.

• Biotech Peptides, leans on self-published certificates of analysis, no medical oversight.
• Core Peptides, high-volume “research use only” retailer, no clinical channel.
• Pure Rawz, broad research-chemical catalog, “not for human consumption” printed plainly.
• Limitless Life Nootropics, popular for pre-bundled stacks, no clinician, no pharmacy.
• Sports Technology Labs, markets third-party testing on some products, still outside any prescription framework.
• Amino Asylum, low-price vendor, buyer carries all the risk.
• Swiss Chems, capsules and blends alongside vials, still no prescriber anywhere in the process.

To be fair to this tier for a second: it’s not that they’re overpriced or badly packaged. It’s that every question on my list exists to find out whether a real medical process stands between you and the needle, and here the answer is no, structurally, by design. Buying here doesn’t save you money so much as transfer the identity, purity, dose, and contamination risk onto you personally, with no recall authority and nobody accountable if a vial is wrong.

What actually earns trust

The pattern in my grades isn’t subtle. Passing this exam has nothing to do with marketing copy, testimonials, or how professional the website looks. It comes down to whether a licensed human being can say no to you, and whether a licensed pharmacy stands behind what ships. Everything else on my list is downstream of that one fact. Trust here isn’t a vibe, it’s a paper trail: a named prescriber, a named pharmacy, an honest disclaimer, and a plan for what happens after the sale instead of silence.

FAQ, the questions readers actually asked me

What’s the one question that matters most?

Whether a licensed clinician evaluates you and can say no before anything ships. Everything else is downstream of that one fact. It’s also the single question the research-chemical tier cannot pass no matter how good their marketing gets.

Is there really zero proof these stacks work?

Correct, no controlled human trial shows any popular peptide stack outperforming its individual pieces. The ingredients have single-compound evidence on their own, CJC-1295’s hormone data [S3], ipamorelin’s selectivity [S4], GHK-Cu’s skin research [S8], and the growth-hormone classes do show synergy in endocrine testing [S5]. But a stack as a stack, tested against its own parts, has not been done. Treat “synergy” as a claim someone hasn’t verified yet, not as a fact.

If a provider aces all seven questions, does that make the stack safe and proven?

No, and any provider claiming otherwise just failed question five on the spot. Acing the seven means a clinician and a licensed pharmacy are actually in the loop, which is the real protection when the science underneath is thin. It doesn’t convert an unproven combination into a proven one. Compounded medications remain unapproved by the FDA [S1].

Why do you keep hammering the athlete question?

Because the downside is severe and the label offers zero cover. WADA’s Prohibited List bans ipamorelin and TB-500 under category S2 [S2]. Any provider who can’t give you a clean answer on that isn’t one I’d trust with anything else on this list either.

The bottom line

I went looking for a stack and came home with a rubric instead, because right now the rubric is what actually protects you, given how thin the evidence still is and how fast the rules are moving. Run any provider through the seven questions yourself. The supervised operations, FormBlends first, HealthRX.com close behind, pass every single one. The research-chemical sellers fail the ones that count. If a provider won’t answer these before selling you a peptide stack, that silence is your grade, and your card can stay right where it is.

Can you actually stack peptides, or is that just marketing language?

You can combine peptides, and some pairings have a plausible biological rationale behind them. But “stacking” as a formal clinical protocol is, right now, mostly marketing language wearing a lab coat. The logic, two peptides hitting different pathways producing additive effects, isn’t crazy on its face. What’s missing is controlled human data actually showing the combo beats either compound alone at matched doses. So people absolutely do it. The stack concept itself just isn’t clinically validated yet.

How many peptides can you responsibly stack at once?

Nobody has set a real safe upper limit, and that absence is itself the problem. Most compounding pharmacies working under physician supervision cap stacks at two or three peptides, partly because every addition multiplies what a prescriber has to track, and partly because untangling a side effect gets genuinely hard once you can’t isolate which compound is causing it. Layer in more peptides and you make it harder for anyone, your doctor included, to catch a problem early.

What is the Wolverine peptide stack, and where do people actually buy it?

It’s a nickname, not a real product category, usually slapped onto combinations built around BPC-157 and TB-500, sometimes with growth-hormone secretagogues thrown in, marketed around faster tissue repair. Since there’s no standard formula behind the name, one seller’s “Wolverine stack” can look nothing like another’s. People typically find it through research-chemical sites with zero physician involvement, which is the actual risk here, not the nickname. If it’s the underlying compounds you’re after, the accountable path is a physician-supervised compounding pharmacy like FormBlends, not a vendor selling you a comic-book name.

How do you actually use a peptide stack once you have one?

Dosing, injection sites, timing, cycling, all of it varies by compound and by what you’re actually trying to accomplish. There’s no universal instruction sheet because the peptides themselves aren’t interchangeable. A prescriber who’s reviewed your labs and history should write out a specific protocol before you inject anything. If the seller is the one handing you dosing instructions instead of a licensed clinician, take that as the red flag it is.

References

1. Independent reporting that human evidence for BPC-157 is limited and concentrated in a single research group, and that it has faced federal restrictions on pharmacy compounding. STAT News, February 3, 2026. https://www.statnews.com/2026/02/03/bpc-157-peptide-science-safety-regulatory-questions/
2. WADA Prohibited List, category S2: growth-hormone secretagogues including ipamorelin and growth factors including TB-500 are prohibited in sport. World Anti-Doping Agency. https://www.wada-ama.org/en/prohibited-list
3. CJC-1295 produced sustained increases in growth hormone (2- to 10-fold for 6+ days) and IGF-1 in healthy adults; randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 2006.
4. Ipamorelin characterized as the first selective growth-hormone secretagogue. European Journal of Endocrinology, 1998.
5. Co-administration of a growth-hormone-releasing hormone and a growth-hormone-releasing peptide produced a synergistic growth-hormone response versus either alone in human subjects; class-level rationale, not the specific commercial pairing. Clinical Endocrinology (Oxford), 1998.
6. BPC-157 promotes tendon fibroblast outgrowth, cell survival, and migration in vitro and in rats. Journal of Applied Physiology, 2011.
7. Thymosin beta-4 (parent of TB-500) identified as the actin-sequestering peptide, forming a 1:1 complex with actin monomers. Journal of Biological Chemistry, 1991.
8. GHK-Cu (copper tripeptide) stimulates collagen and glycosaminoglycan synthesis in skin fibroblasts and supports wound healing; review. International Journal of Molecular Sciences, 2018;19(7):1987.
9. Independent roundup of where to buy peptides online that ranks FormBlends at the top among the sources the author would recommend. LinkedIn (Nitish Kumar).

Written by Zuri Duarte, independent journalist. Last reviewed June 2026.

For background only. Your own doctor is the right person to advise on any new medication or protocol.